United States Toxoid Vaccine Market Report 2017

December 2017 | 103 pages | ID: U9ABBC8EC46EN
QYResearch

Abstracts

In this report, the United States Toxoid Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Toxoid Vaccine in these regions, from 2012 to 2022 (forecast).

United States Toxoid Vaccine market competition by top manufacturers/players, with Toxoid Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi
• Merck
• Pfizer
• Bayer
• Virbac
• GSK
• Ceva Corporate

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By Type 1
• Human Beings
• Animal
• By Type 2
• Injection
• Oral

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinics
• Public Services
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Toxoid Vaccine Market Report 2017

1 TOXOID VACCINE OVERVIEW

1.1 Product Overview and Scope of Toxoid Vaccine
1.2 Classification of Toxoid Vaccine by Product Category
  1.2.1 United States Toxoid Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Toxoid Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Human Beings
  1.2.4 Animal
1.3 United States Toxoid Vaccine Market by Application/End Users
  1.3.1 United States Toxoid Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinics
  1.3.4 Public Services
  1.3.5 Others
1.4 United States Toxoid Vaccine Market by Region
  1.4.1 United States Toxoid Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Toxoid Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Toxoid Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Toxoid Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Toxoid Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Toxoid Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Toxoid Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Toxoid Vaccine (2012-2022)
  1.5.1 United States Toxoid Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Toxoid Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES TOXOID VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Toxoid Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Toxoid Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Toxoid Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Toxoid Vaccine Market Competitive Situation and Trends
  2.4.1 United States Toxoid Vaccine Market Concentration Rate
  2.4.2 United States Toxoid Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Toxoid Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES TOXOID VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Toxoid Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Toxoid Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Toxoid Vaccine Price by Region (2012-2017)

4 UNITED STATES TOXOID VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Toxoid Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Toxoid Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Toxoid Vaccine Price by Type (2012-2017)
4.4 United States Toxoid Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES TOXOID VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Toxoid Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Toxoid Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES TOXOID VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Toxoid Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Toxoid Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.2 Toxoid Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Toxoid Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Toxoid Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Toxoid Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Bayer
  6.4.2 Toxoid Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Bayer Toxoid Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Virbac
  6.5.2 Toxoid Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Virbac Toxoid Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 GSK
  6.6.2 Toxoid Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 GSK Toxoid Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Ceva Corporate
  6.7.2 Toxoid Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Ceva Corporate Toxoid Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 TOXOID VACCINE MANUFACTURING COST ANALYSIS

7.1 Toxoid Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Toxoid Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Toxoid Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Toxoid Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES TOXOID VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Toxoid Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Toxoid Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Toxoid Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Toxoid Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Toxoid Vaccine
Figure United States Toxoid Vaccine Market Size (K Pcs) by Type (2012-2022)
Figure United States Toxoid Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Human Beings Product Picture
Figure Animal Product Picture
Figure United States Toxoid Vaccine Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Toxoid Vaccine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Public Services Examples
Table Key Downstream Customer in Public Services
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Toxoid Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Toxoid Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Toxoid Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Toxoid Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Toxoid Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Toxoid Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Toxoid Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Toxoid Vaccine Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Toxoid Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Toxoid Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Toxoid Vaccine Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Toxoid Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Toxoid Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Toxoid Vaccine Sales Share by Players/Suppliers
Figure United States Toxoid Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Toxoid Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Toxoid Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Toxoid Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Toxoid Vaccine Revenue Share by Players/Suppliers
Table United States Market Toxoid Vaccine Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Toxoid Vaccine Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Toxoid Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Toxoid Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Toxoid Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Toxoid Vaccine Product Category
Table United States Toxoid Vaccine Sales (K Pcs) by Region (2012-2017)
Table United States Toxoid Vaccine Sales Share by Region (2012-2017)
Figure United States Toxoid Vaccine Sales Share by Region (2012-2017)
Figure United States Toxoid Vaccine Sales Market Share by Region in 2016
Table United States Toxoid Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Toxoid Vaccine Revenue Share by Region (2012-2017)
Figure United States Toxoid Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Toxoid Vaccine Revenue Market Share by Region in 2016
Table United States Toxoid Vaccine Price (USD/Pcs) by Region (2012-2017)
Table United States Toxoid Vaccine Sales (K Pcs) by Type (2012-2017)
Table United States Toxoid Vaccine Sales Share by Type (2012-2017)
Figure United States Toxoid Vaccine Sales Share by Type (2012-2017)
Figure United States Toxoid Vaccine Sales Market Share by Type in 2016
Table United States Toxoid Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Toxoid Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Toxoid Vaccine by Type (2012-2017)
Figure Revenue Market Share of Toxoid Vaccine by Type in 2016
Table United States Toxoid Vaccine Price (USD/Pcs) by Types (2012-2017)
Figure United States Toxoid Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Toxoid Vaccine Sales (K Pcs) by Application (2012-2017)
Table United States Toxoid Vaccine Sales Market Share by Application (2012-2017)
Figure United States Toxoid Vaccine Sales Market Share by Application (2012-2017)
Figure United States Toxoid Vaccine Sales Market Share by Application in 2016
Table United States Toxoid Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Toxoid Vaccine Sales Growth Rate by Application (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Toxoid Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Toxoid Vaccine Sales Growth Rate (2012-2017)
Figure Sanofi Toxoid Vaccine Sales Market Share in United States (2012-2017)
Figure Sanofi Toxoid Vaccine Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Toxoid Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Toxoid Vaccine Sales Growth Rate (2012-2017)
Figure Merck Toxoid Vaccine Sales Market Share in United States (2012-2017)
Figure Merck Toxoid Vaccine Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Toxoid Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Toxoid Vaccine Sales Growth Rate (2012-2017)
Figure Pfizer Toxoid Vaccine Sales Market Share in United States (2012-2017)
Figure Pfizer Toxoid Vaccine Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Toxoid Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer Toxoid Vaccine Sales Growth Rate (2012-2017)
Figure Bayer Toxoid Vaccine Sales Market Share in United States (2012-2017)
Figure Bayer Toxoid Vaccine Revenue Market Share in United States (2012-2017)
Table Virbac Basic Information List
Table Virbac Toxoid Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Virbac Toxoid Vaccine Sales Growth Rate (2012-2017)
Figure Virbac Toxoid Vaccine Sales Market Share in United States (2012-2017)
Figure Virbac Toxoid Vaccine Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Toxoid Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Toxoid Vaccine Sales Growth Rate (2012-2017)
Figure GSK Toxoid Vaccine Sales Market Share in United States (2012-2017)
Figure GSK Toxoid Vaccine Revenue Market Share in United States (2012-2017)
Table Ceva Corporate Basic Information List
Table Ceva Corporate Toxoid Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ceva Corporate Toxoid Vaccine Sales Growth Rate (2012-2017)
Figure Ceva Corporate Toxoid Vaccine Sales Market Share in United States (2012-2017)
Figure Ceva Corporate Toxoid Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Toxoid Vaccine
Figure Manufacturing Process Analysis of Toxoid Vaccine
Figure Toxoid Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Toxoid Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Toxoid Vaccine
Table Distributors/Traders List
Figure United States Toxoid Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Toxoid Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Toxoid Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Toxoid Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Toxoid Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Toxoid Vaccine Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Toxoid Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Toxoid Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Toxoid Vaccine Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Toxoid Vaccine Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Toxoid Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Toxoid Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Toxoid Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources